Zhejiang Starry Pharmaceutical Co., Ltd. Class ASSE: 603520

Announcement on Implementation of Dividend Distribution for 2025

· Issued by Zhejiang Starry Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Zhejiang Starry Pharmaceutical Co., Ltd. Class A

All Zhejiang Starry Pharmaceutical Co., Ltd. Class A news releases